{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:12:42Z","timestamp":1794003162090,"version":"4.8.0"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Identification of specific HLA alleles and T-cell epitopes that influence the course of BK polyomavirus (BKPyV) infection after kidney transplantation (KTx), including development of BKPyV-associated nephropathy (BKPyVAN), can be useful for patient risk stratification and possibly vaccine development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>In a retrospective cohort of 407 living kidney donor-recipient pairs, donor and recipient HLA class I and II status were correlated with the occurrence of recipient BKPyV viremia and BKPyVAN in the first year after KTx. Relevant HLA alleles were systematically analyzed for candidate peptide epitopes in silico.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Although none of the 78 HLA alleles analyzed increased the risk of BKPyV viremia and BKPyVAN, a considerable reduction of BKPyV viremia and BKPyVAN cases was observed in HLA-B51\u2013positive KTx recipients. Multivariate analysis showed that HLA-B51 positivity, found in 36 (9%) recipients, reduced the risk of viremia approximately fivefold (hazard ratio, 0.18; 95% confidence interval, 0.04\u20130.73; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.017). Four HLA-B51-restricted putative cytotoxic T lymphocyte epitopes were identified, including a previously described HLA-B supermotif-containing peptide (LPLMRKAYL), encoded by 2 relevant T-antigens (small T and large T) and previously shown to be highly immunogenic.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>In conclusion, HLA-B51-positive kidney transplant recipients were less susceptible to BKPyV infection, which might be explained by efficient presentation of a particular BKPyV-derived immunogenic peptide.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000002376","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T00:37:41Z","timestamp":1532565461000},"page":"604-612","source":"Crossref","is-referenced-by-count":32,"title":["Reduced Risk of BK Polyomavirus Infection in HLA-B51\u2013positive Kidney Transplant Recipients"],"prefix":"10.1097","volume":"103","author":[{"given":"Herman F.","family":"Wunderink","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert W.","family":"Haasnoot","sequence":"additional","affiliation":[{"name":"Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline S.","family":"de Brouwer","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik W.","family":"van Zwet","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aloysius C. M.","family":"Kroes","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan W.","family":"de Fijter","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Leiden University Medical Center, Leiden, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris I.","family":"Rotmans","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Leiden University Medical Center, Leiden, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans H. J.","family":"Claas","sequence":"additional","affiliation":[{"name":"Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariet C. W.","family":"Feltkamp","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/TP.0b013e3182921995","article-title":"Risk factors for BK virus infection in the era of therapeutic drug monitoring.","volume":"95","author":"Borni-Duval","year":"2013","journal-title":"Transplantation"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMoa020439","article-title":"Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients.","volume":"347","author":"Hirsch","year":"2002","journal-title":"N Engl J Med"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/0-387-32957-9_11","article-title":"Polyomavirus-associated nephropathy in renal transplantation: critical issues of screening and management.","volume":"577","author":"Hirsch","year":"2006","journal-title":"Adv Exp Med Biol"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/j.transproceed.2014.08.036","article-title":"Risk factors for BK virus infection and BK virus-associated nephropathy under the impact of intensive monitoring and pre-emptive immunosuppression reduction.","volume":"46","author":"Huang","year":"2014","journal-title":"Transplant Proc"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/TP.0b013e31826690c6","article-title":"Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study.","volume":"94","author":"Sood","year":"2012","journal-title":"Transplantation"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/CMR.00074-16","article-title":"BK polyomavirus: clinical aspects, immune regulation, and emerging therapies.","volume":"30","author":"Ambalathingal","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/ajt.13598","article-title":"Characterization of immunodominant BK polyomavirus 9mer epitope T cell responses.","volume":"16","author":"Cioni","year":"2016","journal-title":"Am J Transplant"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(03)00770-9","article-title":"Polyomavirus BK.","volume":"3","author":"Hirsch","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/apm.12134","article-title":"The human polyomavirus BK (BKPyV): virological background and clinical implications.","volume":"121","author":"Rinaldo","year":"2013","journal-title":"APMIS"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1600-6143.2009.02952.x","article-title":"BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results.","volume":"10","author":"Hardinger","year":"2010","journal-title":"Am J Transplant"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1111\/j.1600-6143.2010.03310.x","article-title":"Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy.","volume":"10","author":"Schaub","year":"2010","journal-title":"Am J Transplant"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2005.00742.x","article-title":"Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction.","volume":"5","author":"Brennan","year":"2005","journal-title":"Am J Transplant"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1111\/j.1600-6143.2007.01984.x","article-title":"Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients.","volume":"7","author":"Ginevri","year":"2007","journal-title":"Am J Transplant"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2215\/CJN.08420813","article-title":"Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation.","volume":"9","author":"Elfadawy","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/01.TP.0000156165.83160.09","article-title":"Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations.","volume":"79","author":"Hirsch","year":"2005","journal-title":"Transplantation"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/TP.0000000000001067","article-title":"BK virus infection after kidney transplantation: the data are mounting for a personalized approach.","volume":"100","author":"Wojciechowski","year":"2016","journal-title":"Transplantation"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/ajt.13880","article-title":"Pretransplantation donor-recipient pair seroreactivity against BK polyomavirus predicts viremia and nephropathy after kidney transplantation.","volume":"17","author":"Wunderink","year":"2017","journal-title":"Am J Transplant"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1097\/TP.0000000000001333","article-title":"BK polyomavirus and the transplanted kidney: immunopathology and therapeutic approaches.","volume":"100","author":"Lamarche","year":"2016","journal-title":"Transplantation"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/j.1600-6143.2005.01000.x","article-title":"Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia.","volume":"5","author":"Bohl","year":"2005","journal-title":"Am J Transplant"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1093\/ndt\/gft298","article-title":"HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK viremia.","volume":"28","author":"Masutani","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00430-015-0398-x","article-title":"Early identification of renal transplant recipients with high risk of polyomavirus-associated nephropathy.","volume":"204","author":"Teutsch","year":"2015","journal-title":"Med Microbiol Immunol"},{"key":"R22-20231002","first-page":"626","article-title":"Rectangular confidence regions for the means of multivariate normal distribuitions.","volume":"318","author":"Sidak","year":"1967","journal-title":"J Am Stat Assoc"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"e81078","DOI":"10.1371\/journal.pone.0081078","article-title":"Different serologic behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 polyomaviruses found on the skin.","volume":"8","author":"van der Meijden","year":"2013","journal-title":"PLoS One"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3201\/eid2006.140055","article-title":"Human polyomavirus 9 infection in kidney transplant patients.","volume":"20","author":"van der Meijden","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0198-8859(93)90143-O","article-title":"Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant.","volume":"37","author":"Verduyn","year":"1993","journal-title":"Hum Immunol"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-60327-118-9_5","article-title":"SYFPEITHI: database for searching and T-cell epitope prediction.","volume":"409","author":"Schuler","year":"2007","journal-title":"Methods Mol Biol"},{"key":"R27-20231002","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0092-8674(79)90209-5","article-title":"The genome of human papovavirus BKV.","volume":"18","author":"Seif","year":"1979","journal-title":"Cell"},{"key":"R28-20231002","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/eji.1830240344","article-title":"A simple assay for detection of peptides promoting the assembly of HLA class I molecules.","volume":"24","author":"Connan","year":"1994","journal-title":"Eur J Immunol"},{"key":"R29-20231002","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.4049\/jimmunol.157.8.3480","article-title":"Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules.","volume":"157","author":"Sidney","year":"1996","journal-title":"J Immunol"},{"issue":"Web Server Issue","key":"R30-20231002","doi-asserted-by":"crossref","first-page":"W525","DOI":"10.1093\/nar\/gks438","article-title":"Immune epitope database analysis resource.","volume":"40","author":"Kim","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"R31-20231002","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bioinformatics\/btv639","article-title":"Gapped sequence alignment using artificial neural networks: application to the MHC class I system.","volume":"32","author":"Andreatta","year":"2016","journal-title":"Bioinformatics"},{"issue":"Web Server Issue","key":"R32-20231002","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkn202","article-title":"NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8\u201311.","volume":"36","author":"Lundegaard","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"R33-20231002","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T-cell epitopes using neural networks with novel sequence representations.","volume":"12","author":"Nielsen","year":"2003","journal-title":"Protein Sci"},{"key":"R34-20231002","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2105-6-132","article-title":"Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method.","volume":"6","author":"Peters","year":"2005","journal-title":"BMC Bioinformatics"},{"key":"R35-20231002","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-7580-4-2","article-title":"Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries.","volume":"4","author":"Sidney","year":"2008","journal-title":"Immunome Res"},{"key":"R36-20231002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00251-014-0808-z","article-title":"HLA dosage effect in narcolepsy with cataplexy.","volume":"67","author":"van der Heide","year":"2015","journal-title":"Immunogenetics"},{"key":"R37-20231002","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jpain.2012.05.003","article-title":"Genetic HLA associations in complex regional pain syndrome with and without dystonia.","volume":"13","author":"van Rooijen","year":"2012","journal-title":"J Pain"},{"key":"R38-20231002","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.24858","article-title":"Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4.","volume":"81","author":"van Sonderen","year":"2017","journal-title":"Ann Neurol"},{"key":"R39-20231002","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1469-1809.1955.tb01285.x","article-title":"The estimation and significance of the logarithm of a ratio of frequencies.","volume":"20","author":"Haldane","year":"1956","journal-title":"Ann Hum Genet"},{"key":"R40-20231002","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1469-1809.1955.tb01348.x","article-title":"On estimating the relation between blood group and disease.","volume":"19","author":"Woolf","year":"1955","journal-title":"Ann Hum Genet"},{"key":"R41-20231002","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fimmu.2016.00286","article-title":"Editorial: role of HLA and KIR in viral infections.","volume":"7","author":"de Wit","year":"2016","journal-title":"Front Immunol"},{"key":"R42-20231002","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1473-3099(14)70965-X","article-title":"Resistance to hepatitis C virus: potential genetic and immunological determinants.","volume":"15","author":"Mina","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"R43-20231002","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3389\/fimmu.2015.00552","article-title":"HLA preferences for conserved epitopes: a potential mechanism for hepatitis C clearance.","volume":"6","author":"Rao","year":"2015","journal-title":"Front Immunol"},{"key":"R44-20231002","doi-asserted-by":"crossref","first-page":"8706","DOI":"10.1073\/pnas.1407307111","article-title":"HLA-B*51 the primary risk in Behcet disease.","volume":"111","author":"Wallace","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R45-20231002","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","article-title":"Behcet\u2019s disease, the Silk Road and HLA-B51: historical and geographical perspectives.","volume":"54","author":"Verity","year":"1999","journal-title":"Tissue Antigens"},{"key":"R46-20231002","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1016\/j.transproceed.2013.08.098","article-title":"Cytomegalovirus infection in renal transplant recipients: one center\u2019s experience.","volume":"45","author":"Bal","year":"2013","journal-title":"Transplant Proc"},{"key":"R47-20231002","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0198-8859(02)00741-3","article-title":"The association of class I HLA alleles and antibody levels after a single dose of measles vaccine.","volume":"64","author":"Jacobson","year":"2003","journal-title":"Hum Immunol"},{"key":"R48-20231002","doi-asserted-by":"crossref","first-page":"684","DOI":"10.4049\/jimmunol.1100316","article-title":"Multilayered defense in HLA-B51-associated HIV viral control.","volume":"187","author":"Zhang","year":"2011","journal-title":"J Immunol"},{"key":"R49-20231002","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0198-8859(98)00113-X","article-title":"Identification of multiple HIV-1 CTL epitopes presented by HLA-B*5101 molecules.","volume":"60","author":"Tomiyama","year":"1999","journal-title":"Hum Immunol"},{"key":"R50-20231002","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/iji.12219","article-title":"HLA B51 is associated with faster AIDS progression among newly diagnosed HIV-infected individuals in Manitoba Canada.","volume":"42","author":"Keynan","year":"2015","journal-title":"Int J Immunogenet"},{"key":"R51-20231002","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1086\/511647","article-title":"Associations among Epstein-Barr virus subtypes, human leukocyte antigen class I alleles, and the development of posttransplantation lymphoproliferative disorder in bone marrow transplant recipients.","volume":"44","author":"Gorzer","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R52-20231002","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0960-5428(06)80273-1","article-title":"CMV-specific immune responses and HLA phenotypes of AIDS patients who develop CMV retinitis. HNRC Group. HIV Neurobehavioral Research Center.","volume":"4","author":"Schrier","year":"1994","journal-title":"Adv Neuroimmunol"},{"key":"R53-20231002","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/sj.bmt.1702244","article-title":"Association of cytomegalovirus interstitial pneumonitis with HLA-type following allogeneic bone marrow transplantation.","volume":"25","author":"Yamada","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R54-20231002","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/art.24642","article-title":"HLA-B51\/B5 and the risk of Behcet\u2019s disease: a systematic review and meta-analysis of case\u2013control genetic association studies.","volume":"61","author":"de Menthon","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R55-20231002","doi-asserted-by":"crossref","first-page":"9680","DOI":"10.1074\/jbc.M117.789180","article-title":"The Behcet\u2019s disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing.","volume":"292","author":"Guasp","year":"2017","journal-title":"J Biol Chem"},{"key":"R56-20231002","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/1547691X.2017.1346008","article-title":"Genetics and immunodysfunction underlying Behcet\u2019s disease and immunomodulant treatment approaches.","volume":"14","author":"Salmaninejad","year":"2017","journal-title":"J Immunotoxicol"},{"key":"R57-20231002","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00296-006-0281-6","article-title":"Immunopathogenesis of Behcet\u2019s disease with special emphasize on the possible role of antigen presenting cells.","volume":"27","author":"Pay","year":"2007","journal-title":"Rheumatol Int"},{"key":"R58-20231002","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1111\/ajt.14282","article-title":"BK polyomavirus-specific 9mer CD8 T cell responses correlate with clearance of BK viremia in kidney transplant recipients: first report from the Swiss Transplant Cohort Study.","volume":"17","author":"Leboeuf","year":"2017","journal-title":"Am J Transplant"},{"issue":"Pt 10","key":"R59-20231002","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1099\/vir.0.82094-0","article-title":"T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus.","volume":"87","author":"Li","year":"2006","journal-title":"J Gen Virol"},{"key":"R60-20231002","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4049\/jimmunol.154.1.247","article-title":"Several HLA alleles share overlapping peptide specificities.","volume":"154","author":"Sidney","year":"1995","journal-title":"J Immunol"},{"key":"R61-20231002","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00251-004-0647-4","article-title":"Definition of supertypes for HLA molecules using clustering of specificity matrices.","volume":"55","author":"Lund","year":"2004","journal-title":"Immunogenetics"},{"key":"R62-20231002","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/ki.2013.59","article-title":"The genetic predisposition of natural killer cell to BK virus-associated nephropathy in renal transplant patients.","volume":"84","author":"Trydzenskaya","year":"2013","journal-title":"Kidney Int"},{"key":"R63-20231002","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1600-6143.2008.02242.x","article-title":"The number of activating KIR genes inversely correlates with the rate of CMV infection\/reactivation in kidney transplant recipients.","volume":"8","author":"Stern","year":"2008","journal-title":"Am J Transplant"},{"key":"R64-20231002","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1600-6143.2011.03516.x","article-title":"Telomeric rather than centromeric activating KIR genes protect from cytomegalovirus infection after kidney transplantation.","volume":"11","author":"Stern","year":"2011","journal-title":"Am J Transplant"},{"key":"R65-20231002","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/tri.12820","article-title":"The association between killer-cell immunoglobulin-like receptor (KIR) and KIR ligand genotypes and the likelihood of BK virus replication after kidney transplantation.","volume":"29","author":"Brochot","year":"2016","journal-title":"Transpl Int"},{"key":"R66-20231002","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/ajt.13684","article-title":"The \u201cABC\u201d of virus-specific T cell immunity in solid organ transplantation.","volume":"16","author":"Sester","year":"2016","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007890-201903000-00029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:25:59Z","timestamp":1696224359000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201903000-00029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002376","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}